Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 26002307)

Published in Radiother Oncol on May 19, 2015

Authors

Peter S N van Rossum1, Astrid L H M W van Lier2, Marco van Vulpen2, Onne Reerink2, Jan J W Lagendijk2, Steven H Lin3, Richard van Hillegersberg4, Jelle P Ruurda4, Gert J Meijer5, Irene M Lips2

Author Affiliations

1: Department of Radiotherapy, University Medical Center Utrecht, The Netherlands; Department of Surgery, University Medical Center Utrecht, The Netherlands. Electronic address: P.S.N.vanRossum-2@umcutrecht.nl.
2: Department of Radiotherapy, University Medical Center Utrecht, The Netherlands.
3: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
4: Department of Surgery, University Medical Center Utrecht, The Netherlands.
5: Department of Radiotherapy, University Medical Center Utrecht, The Netherlands. Electronic address: G.J.Meijer@umcutrecht.nl.